Arthur He's Stock Ratings

HC Wainwright & Co. Analyst

Arthur He is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025

Updated: Dec 15, 2025

Overall Average Return

27.5%

Smart Score

70.6%

Overall Average Return Percentile

84th

Number of Ratings

91
Buy NowGet Alert
11/10/2025VERABuy Now
Vera Therapeutics
$47.7488.52%$85 → $90MaintainsBuyGet Alert
08/15/2025ADAGBuy Now
Adagene
$1.99251.76%$8 → $7MaintainsBuyGet Alert
08/05/2025LVTXBuy Now
LAVA Therapeutics
——$1.5 → $1.24MaintainsNeutralGet Alert
07/30/2025AUPHBuy Now
Aurinia Pharmaceuticals
$15.539.47% → $17Assumes → BuyGet Alert
07/29/2025ADAPBuy Now
Adaptimmune Therapeutics
———DowngradeBuy → NeutralGet Alert
06/24/2025NKTRBuy Now
Nektar Therapeutics
$58.80104.08%$6.5 → $120MaintainsBuyGet Alert
06/17/2025SLDBBuy Now
Solid Biosciences
$5.71250.26%$20 → $20ReiteratesBuy → BuyGet Alert
06/02/2025VERABuy Now
Vera Therapeutics
$47.7478.05%$75 → $85MaintainsBuyGet Alert
05/20/2025PRMEBuy Now
Prime Medicine
$4.01——DowngradeBuy → NeutralGet Alert
05/05/2025VERABuy Now
Vera Therapeutics
$47.7457.1% → $75Assumes → BuyGet Alert
04/03/2025ADAGBuy Now
Adagene
$1.99302.01%$8 → $8ReiteratesBuy → BuyGet Alert
04/01/2025ADAPBuy Now
Adaptimmune Therapeutics
——$3.5 → $3MaintainsBuyGet Alert
03/31/2025BCABBuy Now
BioAtla
$0.81——ReiteratesNeutral → NeutralGet Alert
03/31/2025LVTXBuy Now
LAVA Therapeutics
——$1.5 → $1.5ReiteratesNeutral → NeutralGet Alert
03/19/2025PRMEBuy Now
Prime Medicine
$4.01149.38%$10 → $10ReiteratesBuy → BuyGet Alert
03/13/2025NKTRBuy Now
Nektar Therapeutics
$58.80-88.95%$6.5 → $6.5ReiteratesBuy → BuyGet Alert
03/10/2025SLDBBuy Now
Solid Biosciences
$5.71250.26%$16 → $20MaintainsBuyGet Alert
03/03/2025PRMEBuy Now
Prime Medicine
$4.01149.38%$10 → $10ReiteratesBuy → BuyGet Alert
02/27/2025LVTXBuy Now
LAVA Therapeutics
——$2 → $1.5DowngradeBuy → NeutralGet Alert
02/25/2025NKTRBuy Now
Nektar Therapeutics
$58.80-88.95%$6.5 → $6.5ReiteratesBuy → BuyGet Alert
01/27/2025ADAGBuy Now
Adagene
$1.99302.01%$5 → $8MaintainsBuyGet Alert
01/13/2025SLDBBuy Now
Solid Biosciences
$5.71180.21%$16 → $16ReiteratesBuy → BuyGet Alert
01/13/2025NKTRBuy Now
Nektar Therapeutics
$58.80-88.95%$6.5 → $6.5ReiteratesBuy → BuyGet Alert
01/10/2025SLDBBuy Now
Solid Biosciences
$5.71180.21%$16 → $16ReiteratesBuy → BuyGet Alert
01/10/2025HOOKBuy Now
HOOKIPA Pharma
$0.88——DowngradeBuy → NeutralGet Alert
12/20/2024LVTXBuy Now
LAVA Therapeutics
——$6 → $2MaintainsBuyGet Alert
12/12/2024SLDBBuy Now
Solid Biosciences
$5.71180.21%$16 → $16ReiteratesBuy → BuyGet Alert
11/26/2024PSTXBuy Now
Poseida Therapeutics
——$20 → $9DowngradeBuy → NeutralGet Alert
11/19/2024ADAPBuy Now
Adaptimmune Therapeutics
——$3.5 → $3.5ReiteratesBuy → BuyGet Alert
11/15/2024PSTXBuy Now
Poseida Therapeutics
——$20 → $20ReiteratesBuy → BuyGet Alert
11/14/2024ADAPBuy Now
Adaptimmune Therapeutics
——$4 → $3.5MaintainsBuyGet Alert
11/13/2024BCABBuy Now
BioAtla
$0.81——DowngradeBuy → NeutralGet Alert
11/13/2024PRMEBuy Now
Prime Medicine
$4.01149.38%$10 → $10ReiteratesBuy → BuyGet Alert
11/08/2024PSTXBuy Now
Poseida Therapeutics
——$20 → $20ReiteratesBuy → BuyGet Alert
11/07/2024SLDBBuy Now
Solid Biosciences
$5.71180.21%$16 → $16ReiteratesBuy → BuyGet Alert
10/30/2024PSTXBuy Now
Poseida Therapeutics
——$20 → $20ReiteratesBuy → BuyGet Alert
10/25/2024PRMEBuy Now
Prime Medicine
$4.01149.38%$10 → $10ReiteratesBuy → BuyGet Alert
10/17/2024PSTXBuy Now
Poseida Therapeutics
——$20 → $20ReiteratesBuy → BuyGet Alert
10/02/2024PRMEBuy Now
Prime Medicine
$4.01149.38%$10 → $10ReiteratesBuy → BuyGet Alert
09/18/2024ADAGBuy Now
Adagene
$1.99151.26%$5 → $5ReiteratesBuy → BuyGet Alert
08/14/2024SLDBBuy Now
Solid Biosciences
$5.71180.21%$16 → $16ReiteratesBuy → BuyGet Alert
08/13/2024ADAPBuy Now
Adaptimmune Therapeutics
——$4 → $4ReiteratesBuy → BuyGet Alert
08/09/2024PRMEBuy Now
Prime Medicine
$4.01149.38%$10 → $10ReiteratesBuy → BuyGet Alert
08/06/2024PSTXBuy Now
Poseida Therapeutics
——$20 → $20ReiteratesBuy → BuyGet Alert
08/05/2024ADAPBuy Now
Adaptimmune Therapeutics
——$4 → $4ReiteratesBuy → BuyGet Alert
07/30/2024ADAPBuy Now
Adaptimmune Therapeutics
—— → $4Initiates → BuyGet Alert
07/25/2024PSTXBuy Now
Poseida Therapeutics
——$20 → $20ReiteratesBuy → BuyGet Alert
07/22/2024ADAGBuy Now
Adagene
$1.99151.26%$5 → $5ReiteratesBuy → BuyGet Alert
06/28/2024ADAGBuy Now
Adagene
$1.99151.26%$5 → $5ReiteratesBuy → BuyGet Alert
06/28/2024LVTXBuy Now
LAVA Therapeutics
——$6 → $6ReiteratesBuy → BuyGet Alert
06/05/2024HOOKBuy Now
HOOKIPA Pharma
$0.88580.66%$5 → $6MaintainsBuyGet Alert
05/28/2024CALTBuy Now
Calliditas Therapeutics
—— → $39DowngradeBuy → NeutralGet Alert
05/24/2024CALTBuy Now
Calliditas Therapeutics
——$50 → $45MaintainsBuyGet Alert
05/22/2024PSTXBuy Now
Poseida Therapeutics
—— → $20ReiteratesBuy → BuyGet Alert
05/20/2024SLDBBuy Now
Solid Biosciences
$5.71180.21%$16 → $16ReiteratesBuy → BuyGet Alert
05/20/2024PRMEBuy Now
Prime Medicine
$4.01149.38% → $10Initiates → BuyGet Alert
05/15/2024BCABBuy Now
BioAtla
$0.81759.85%$7 → $7ReiteratesBuy → BuyGet Alert
05/02/2024PSTXBuy Now
Poseida Therapeutics
——$20 → $20ReiteratesBuy → BuyGet Alert
04/26/2024HOOKBuy Now
HOOKIPA Pharma
$0.88467.21%$6.5 → $5MaintainsBuyGet Alert
04/22/2024PSTXBuy Now
Poseida Therapeutics
——$20 → $20ReiteratesBuy → BuyGet Alert
03/27/2024BCABBuy Now
BioAtla
$0.81759.85%$10 → $7MaintainsBuyGet Alert
03/25/2024HOOKBuy Now
HOOKIPA Pharma
$0.88637.38%$6.5 → $6.5ReiteratesBuy → BuyGet Alert
03/21/2024LVTXBuy Now
LAVA Therapeutics
——$6 → $6ReiteratesBuy → BuyGet Alert
03/14/2024SLDBBuy Now
Solid Biosciences
$5.71180.21%$16 → $16ReiteratesBuy → BuyGet Alert
03/11/2024SLDBBuy Now
Solid Biosciences
$5.71180.21%$9 → $16MaintainsBuyGet Alert
03/08/2024PSTXBuy Now
Poseida Therapeutics
——$20 → $20ReiteratesBuy → BuyGet Alert
02/22/2024CALTBuy Now
Calliditas Therapeutics
——$50 → $50ReiteratesBuy → BuyGet Alert
12/11/2023PSTXBuy Now
Poseida Therapeutics
——$15 → $20MaintainsBuyGet Alert
11/27/2023CALTBuy Now
Calliditas Therapeutics
—— → $50ReiteratesBuy → BuyGet Alert
11/17/2023LVTXBuy Now
LAVA Therapeutics
—— → $6ReiteratesBuy → BuyGet Alert
11/08/2023BCABBuy Now
BioAtla
$0.811128.35%$17 → $10MaintainsBuyGet Alert
10/04/2023ADAGBuy Now
Adagene
$1.99151.26% → $5ReiteratesBuy → BuyGet Alert
09/01/2023ADAGBuy Now
Adagene
$1.99151.26% → $5ReiteratesBuy → BuyGet Alert
08/23/2023LVTXBuy Now
LAVA Therapeutics
——$9 → $6MaintainsBuyGet Alert
08/11/2023HOOKBuy Now
HOOKIPA Pharma
$0.88637.38%$8 → $6.5MaintainsBuyGet Alert
08/08/2023PSTXBuy Now
Poseida Therapeutics
—— → $15ReiteratesBuy → BuyGet Alert
08/02/2023BCABBuy Now
BioAtla
$0.811988.2% → $17ReiteratesBuy → BuyGet Alert
06/12/2023LVTXBuy Now
LAVA Therapeutics
—— → $9ReiteratesBuy → BuyGet Alert
05/23/2023PSTXBuy Now
Poseida Therapeutics
—— → $15ReiteratesBuy → BuyGet Alert
05/15/2023BCABBuy Now
BioAtla
$0.811988.2% → $17ReiteratesBuy → BuyGet Alert
05/12/2023HOOKBuy Now
HOOKIPA Pharma
$0.88807.54% → $8ReiteratesBuy → BuyGet Alert
05/10/2023PSTXBuy Now
Poseida Therapeutics
—— → $15Reiterates → BuyGet Alert
04/21/2023ADAGBuy Now
Adagene
$1.99151.26% → $5Reiterates → BuyGet Alert
04/13/2023LVTXBuy Now
LAVA Therapeutics
—— → $9Reiterates → BuyGet Alert
03/29/2023ADAGBuy Now
Adagene
$1.99151.26% → $5Reiterates → BuyGet Alert
03/24/2023BCABBuy Now
BioAtla
$0.811988.2%$20 → $17MaintainsBuyGet Alert
03/21/2023ADAGBuy Now
Adagene
$1.99151.26% → $5Reiterates → BuyGet Alert
03/16/2023HOOKBuy Now
HOOKIPA Pharma
$0.88807.54% → $8Reiterates → BuyGet Alert
03/10/2023PSTXBuy Now
Poseida Therapeutics
—— → $15Reiterates → BuyGet Alert
02/23/2023PSTXBuy Now
Poseida Therapeutics
—— → $15MaintainsBuyGet Alert
10/25/2022LVTXBuy Now
LAVA Therapeutics
—— → $9Initiates → BuyGet Alert

Recent Analyst Stock Rating News

Bitcoin, Ethereum And Dogecoin Erased Their 2025 Gains, But This Privacy-Focused Coin Is This Year's Best Performing Crypto With Over 600% Returns
Bitcoin, Ethereum And Dogecoin Erased Their 2025 Gains, But This Privacy-Focused Coin Is This Year's Best Performing Crypto With Over 600% Returns
The premium cryptocurrencies may have lost all of their yearly gains amid the ongoing correction, but Zcash (CRYPTO: ZEC) has stood tall, delivering impressive returns
Bitcoin, Ethereum, XRP, Dogecoin Extend Declines As Liquidations Near $1 Billion
Bitcoin, Ethereum, XRP, Dogecoin Extend Declines As Liquidations Near $1 Billion
Bitcoin fell below the $85,000 level on Monday as market sentiment weakened amid rising speculation over a potential rate hike in Japan.  
Arthur Hayes Questions Tether's Solvency: Leading Crypto Analyst Asks Grok To Compare Stablecoin Issuer With Traditional Banks And Here's What It Said
Arthur Hayes Questions Tether's Solvency: Leading Crypto Analyst Asks Grok To Compare Stablecoin Issuer With Traditional Banks And Here's What It Said
Well-known cryptocurrency analyst Willy Woo asked an AI agent to provide a comparative analysis of Tether's (CRYPTO: USDT) asset backing versus a tradition
Trump's Crypto Ties Come Under Fire From House Democrats: 'The Most Corrupt Crypto Startup Operation'
Trump's Crypto Ties Come Under Fire From House Democrats: 'The Most Corrupt Crypto Startup Operation'
House Democrats accuse Trump Media & Technology Group Corp. (NASDAQ:DJT) of turning the White House into an engine for an $800 million crypto windfall in 2025, according t
Here Is Jeff Bezos' Most Expensive Investment, And It Is The Largest In The World
Here Is Jeff Bezos' Most Expensive Investment, And It Is The Largest In The World
Amazon founder Jeff Bezos has reportedly invested a staggering $500 million in a superyacht, setting a new record for the largest sailing yacht in the world.
Eric Schmidt Says Free Chinese AI Models Could Overtake Western Systems In Global Use
Eric Schmidt Says Free Chinese AI Models Could Overtake Western Systems In Global Use
Former Google CEO Eric Schmidt cautions about cost and accessibility of AI models, which could lead to global reliance on Chinese technology.
Bitcoin Has 'High Probability' Of Crashing Below $60,000 If It Stays Below This Level, Says Analyst, But The Fall Could Be Even Steeper
Bitcoin Has 'High Probability' Of Crashing Below $60,000 If It Stays Below This Level, Says Analyst, But The Fall Could Be Even Steeper
A renowned cryptocurrency analyst shared a cautious perspective on Bitcoin’s (CRYPTO: BTC) price on Sunday, hinting at a sharp drop from the current levels.
Wall Street Braces For $6.6 Trillion Fed Shift Amid Bitcoin Price Surge
Wall Street Braces For $6.6 Trillion Fed Shift Amid Bitcoin Price Surge
Wall Street is discreetly gearing up for a significant alteration in the Federal Reserve’s $6.6 trillion balance sheet, coinciding with a sudden rise in Bitcoin‘s (CRYPTO: BTC) price.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved